SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $8,000 | +14.3% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $7,000 | -50.0% | 3,000 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $14,000 | -39.1% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $23,000 | -53.1% | 3,000 | -40.7% | 0.00% | -55.6% |
| Q2 2021 | $49,000 | +16.7% | 5,059 | 0.0% | 0.01% | +12.5% |
| Q1 2021 | $42,000 | -23.6% | 5,059 | -37.2% | 0.01% | -33.3% |
| Q4 2020 | $55,000 | -38.9% | 8,059 | 0.0% | 0.01% | -42.9% |
| Q3 2020 | $90,000 | +190.3% | 8,059 | +65.5% | 0.02% | +200.0% |
| Q2 2020 | $31,000 | +287.5% | 4,870 | +16.0% | 0.01% | +250.0% |
| Q1 2020 | $8,000 | -27.3% | 4,200 | +31.2% | 0.00% | -33.3% |
| Q4 2019 | $11,000 | +57.1% | 3,200 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $7,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |